Rights and permissions
About this article
Cite this article
Adding cetuximab to RT: ahead for cost effectiveness in Taiwan. Pharmacoecon. Outcomes News 640, 3 (2011). https://doi.org/10.2165/00151234-201106400-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106400-00006